The Scientific Program Committee is pleased to announce the Opening Session speakers for the 34th Conference on Retroviruses and Opportunistic Infections (CROI), to be held March 21 to 24, 2027, in San Diego, California.

We are also excited to share an early glance at the CROI 2027 scientific program. Abstract submission will open on August 27, 2026, and the updated abstract categories are now available on the CROI website.

CROI 2027 Opening Session

BERNARD FIELDS LECTURE

Alexandra Trkola

Alexandra Trkola
University of Zurich, Switzerland

From Observation to Discovery to Intervention: Broadly Neutralizing Antibodies Against HIV

The Bernard Fields Lecture recognizes a basic scientist for their important contributions to the fields of virology and viral pathogenesis.

MARTIN DELANEY PRESENTATION

Tori Cooper

Tori Cooper
Human Rights Campaign
Atlanta, GA, USA

No One Is Expendable: Transgender Rights Are Human Rights and Advocate Is a Noun and a Verb

The Martin Delaney Presentation recognizes the important contributions of community advocacy and engagement to HIV research.

N’GALY-MANN LECTURE

Pedro Cahn

Pedro Cahn
Fundación Huésped
Buenos Aires, Argentina

HIV: The Unfinished Epidemic in an Increasingly Unequal Society

The N’Galy-Mann Lecture recognizes an HIV/AIDS researcher for their important work in the fields of epidemiology/public health or clinical research.

Scientific Program Preview

CROI 2027 plenary presentations will explore major scientific, clinical, and public health questions across the HIV research continuum, including:

  • The future of antiretroviral therapy
  • Pediatric HIV and cure research
  • Implementation science in HIV prevention
  • HIV infection of the central nervous system
  • Vaccine-preventable diseases in people with HIV
  • Cancer in people with HIV

The CROI 2027 symposia will provide in-depth discussions on a broad range of timely topics, including:

  • Integrating HIV treatment and prevention into primary care
  • Novel immunotherapy approaches
  • Mortality among people with HIV
  • Hepatitis B in the care of people with HIV
  • HIV envelope biology and its translational implications
  • Low-level viremia and its clinical significance
  • HIV and substance use
  • Early translational approaches to HIV reservoir reduction and cure

Additional details, including session descriptions, presentation titles, and faculty, are available on the CROI 2027 Preliminary Program page.

Abstract Submission Opens August 27

CROI welcomes consequential original research on HIV, hepatitis viruses, SARS-CoV-2, mpox, and emerging viral infections and related conditions.

Researchers planning to submit an abstract are encouraged to review the CROI 2027 abstract submission categories before general abstract submission opens on August 27 and closes on October 1.

Additional details about the scientific program, abstract submission, scholarships, registration, and other important dates will be announced as they become available.

We look forward to welcoming the global HIV research community to San Diego for CROI 2027.

Warm regards,

Wafaa El-Sadr, MD, MPH
Chair, CROI 2027
Professor of Epidemiology and Medicine
Columbia University